Shilps Sciences is a healthtech platform that claims to have solved gene editing by accelerating single gene cell applications. Shilps Sciences is backed by investors that include AngelList India and is headquartered in Bengaluru.
INDUSTRY:
Biotechnology, Health Care, Therapeutics
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
